Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i> -Mutant Lung CancerAdam J. Schoenfeld, Helena A. Yu, Joseph M. Chan et al.|Clinical Cancer Research|2020Cited by 381
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic SarcomasNatasha Rekhtman, William D. Travis, Joseph Montecalvo et al.|Journal of Thoracic Oncology|2019Cited by 307
The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung CancerAdam J. Schoenfeld, Gregory J. Riely, Maria E. Arcila et al.|Clinical Cancer Research|2020Cited by 281
Automated real-world data integration improves cancer outcome predictionJustin Jee, Rona Yaeger, Christopher J. Fong et al.|Nature|2024Cited by 148
Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene RearrangementsJason C. Chang, Cristina R. Antonescu|Journal of Thoracic Oncology|2018Cited by 80